Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porterโs Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Biosurgery Market, by Product
6.1 Introduction
6.2 Bone-Graft Substitutes
6.2.1 Demineralized Bone Matrix
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
6.2.2 Synthetic Bone Grafts
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
6.2.3 Bone Morphogenetic Proteins
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
6.2.4 Other Bone-Graft Substitutes
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
6.3 Hemostatic Agents
6.3.1 Thrombin-Based Hemostatic Agents
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
6.3.2 Oxidized Regenerated Cellulose-Based Hemostatic Agents
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
6.3.3 Combination Hemostatic Agents
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
6.4 Soft-Tissue Attachments
6.4.1 Synthetic Meshes
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
6.4.2 Biological Meshes
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
6.5 Surgical Sealants and Adhesives
6.5.1 Natural Sealants and Adhesives
6.5.1.1 Fibrin Sealants
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
6.5.1.2 Collagen-Based Sealants
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
6.5.1.3 Gelatin-Based Sealants
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
6.5.1.4 Albumin-Based Sealants
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
6.5.1.5 Other Natural Sealants
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
6.5.2 Synthetic Sealants and Adhesives
6.5.2.1 Peg Hydrogels
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
6.5.2.2 Cyanoacrylate-Based Sealants and Adhesives
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
6.5.2.3 Urethane-Based Sealants and Adhesives
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
6.5.2.4 Other Synthetic Sealants and Adhesives
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
6.6 Adhesion Barriers
6.6.1 Synthetic Adhesion Barriers
6.6.1.1 Hyaluronic Acid-Based Adhesion Barriers
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
6.6.1.2 Regenerated Cellulose-Based Adhesion Barriers
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
6.6.1.3 Peg-Based Adhesion Barriers
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
6.6.1.4 Ther Synthetic Adhesion Barriers
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
6.6.2 Natural Adhesion Barriers
6.6.2.1 Collagen & Protein Adhesion Barriers
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
6.6.2.2 Fibrin-Based Adhesion Barriers
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
6.7 Staple-Line Reinforcement Agents
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
Chapter 7. Global Biosurgery Market, by Source
7.1 Introduction
7.2 Biologics Products
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
7.3 Synthetic Products
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
Chapter 8. Global Biosurgery Market, by Application
8.1 Introduction
8.2 Neurological Surgery
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
8.3 General Surgery
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
8.4 Cardiovascular Surgery
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
8.5 Orthopedic Surgery
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
8.6 Thoracic Surgery
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
8.7 Gynecology Surgery
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
8.8 Reconstructive Surgery
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
8.9 Urology Surgery
Market Estimates & Forecast, by Region, 2018โ2023
Market Estimates & Forecast, by Country, 2018โ2023
Chapter 9. Global Biosurgery Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
Chapter 11. Company Profiles
11.1 B.Braun Melsungen AG
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Baxter International, Inc.
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Johnson & Johnson
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 C.R. Bard
11.4.1 Company Overview
11.4.2 Technology/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Medtronic, PLC.
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 MAQUET Holding B.V. & Co. Kg. (Getinge Group)
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Cohera Medical Inc.
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Integra Lifesciences Holdings Corporation
11.8.1 Overview
11.8.2 Product/ Technology Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Commonwealth Serum Laboratories (CSL)
11.9.1 Overview
11.9.2 Product Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Hemostasis, LLC
11.10.1 Overview
11.10.2 Product Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.11 Sanofi
11.11.1 Overview
11.11.2 Product Overview
11.11.3 Financials
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.12 Stryker Corporation
11.12.1 Overview
11.12.2 Product Overview
11.12.3 Financials
11.12.4 Key Developments
11.12.5 SWOT Analysis
11.13 Pfizer Inc.
11.13.1 Overview
11.13.2 Product Overview
11.13.3 Financials
11.13.4 Key Developments
11.13.5 SWOT Analysis
11.14 Cryolife, Inc.
11.14.1 Overview
11.14.2 Product Overview
11.14.3 Financials
11.14.4 Key Developments
11.14.5 SWOT Analysis
11.15 Kuros Biosciences Ltd.
11.15.1 Overview
11.15.2 Product Overview
11.15.3 Financials
11.15.4 Key Developments
11.15.5 SWOT Analysis
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEOโs Viewpoint
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Predictions for the Biosurgery Industry
Chapter 13. Appendix
LIST OF TABLES
Table 1 Global Biosurgery Market Synopsis, 2018โ2023
Table 2 Global Biosurgery Market Estimates and Forecast, 2018โ2023 (USD Million)
Table 3 Global Biosurgery Market, by Region, 2018โ2023 (USD Million)
Table 4 Global Biosurgery Market, by Product, 2018โ2023 (USD Million)
Table 5 Global Biosurgery Market, by Source, 2018โ2023 (USD Million)
Table 6 Global Biosurgery Market, by Application, 2018โ2023 (USD Million)
Table 7 North America: Biosurgery Market, by Product, 2018โ2023 (USD
Million)
Table 8 North America: Biosurgery Market, by Source, 2018โ2023 (USD
Million)
Table 9 North America: Biosurgery Market, by Application, 2018โ2023 (USD
Million)
Table 10 US: Biosurgery Market, by Product, 2018โ2023 (USD Million)
Table 11 US: Biosurgery Market, by Source, 2018โ2023 (USD Million)
Table 12 US: Biosurgery Market, by Application, 2018โ2023 (USD Million)
Table 13 Canada: Biosurgery Market, by Product, 2018โ2023 (USD Million)
Table 14 Canada: Biosurgery Market, by Source, 2018โ2023 (USD Million)
Table 15 Canada: Biosurgery Market, by Application, 2018โ2023 (USD
Million)
Table 16 South America: Biosurgery Market, by Product, 2018โ2023 (USD
Million)
Table 17 South America: Biosurgery Market, by Source, 2018โ2023 (USD
Million)
Table 18 South America: Biosurgery Market, by Application, 2018โ2023 (USD
Million)
Table 19 Europe: Biosurgery Market, by Product, 2018โ2023 (USD Million)
Table 20 Europe: Biosurgery Market, by Source, 2018โ2023 (USD Million)
Table 21 Europe: Biosurgery Market, by Application, 2018โ2023 (USD Million)
Table 22 Western Europe: Biosurgery Market, by Product, 2018โ2023 (USD
Million)
Table 23 Western Europe: Biosurgery Market, by Source, 2018โ2023 (USD
Million)
Table 24 Western Europe: Biosurgery Market, by Application, 2018โ2023
(USD Million)
Table 25 Eastern Europe: Biosurgery Market, by Product, 2018โ2023 (USD
Million)
Table 26 Eastern Europe: Biosurgery Market, by Source, 2018โ2023 (USD
Million)
Table 27 Eastern Europe: Biosurgery Market, by Application, 2018โ2023
(USD Million)
Table 28 Asia-Pacific: Biosurgery Market, by Product, 2018โ2023 (USD
Million)
Table 29 Asia-Pacific: Biosurgery Market, by Source, 2018โ2023 (USD
Million)
Table 30 Asia-Pacific: Biosurgery Market, by Application, 2018โ2023 (USD
Million)
Table 31 Middle East & Africa: Biosurgery Market, by Product, 2018โ2023
(USD Million)
Table 32 Middle East & Africa: Biosurgery Market, by Source, 2018โ2023
(USD Million)
Table 33 Middle East & Africa: Biosurgery Market, by Application, 2018โ2023
(USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Biosurgery Market
Figure 3 Segmentation Market Dynamics for Global Biosurgery Market
Figure 4 Global Biosurgery Market Share, by Product, 2020
Figure 5 Global Biosurgery Market Share, by Source, 2020
Figure 6 Global Biosurgery Market Share, by Application, 2020
Figure 7 Global Biosurgery Market Share, by Region, 2020
Figure 8 North America: Biosurgery Market Share, by Country, 2020
Figure 9 Europe: Biosurgery Market Share, by Country, 2020
Figure 10 Asia-Pacific: Biosurgery Market Share, by Country, 2020
Figure 11 Middle East & Africa: Biosurgery Market Share, by Country, 2020
Figure 12 Global Biosurgery Market: Company Share Analysis, 2020 (%)
Figure 13 B.Braun Melsungen AG: Key Financials
Figure 14 B.Braun Melsungen AG: Segmental Revenue
Figure 15 B.Braun Melsungen AG: Geographical Revenue
Figure 16 Baxter International, Inc.: Key Financials
Figure 17 Baxter International, Inc.: Segmental Revenue
Figure 18 Baxter International, Inc.: Geographical Revenue
Figure 19 Johnson & Johnson: Key Financials
Figure 20 Johnson & Johnson: Segmental Revenue
Figure 21 Johnson & Johnson: Geographical Revenue
Figure 22 C.R. Bard: Key Financials
Figure 23 C.R. Bard: Segmental Revenue
Figure 24 C.R. Bard: Geographical Revenue
Figure 25 Medtronic, PLC.: Key Financials
Figure 26 Medtronic, PLC.: Segmental Revenue
Figure 27 Medtronic, PLC.. Geographical Revenue
Figure 28 MAQUET Holding B.V. & Co. Kg. (Getinge Group): Key Financials
Figure 29 MAQUET Holding B.V. & Co. Kg. (Getinge Group): Segmental Revenue
Figure 30 MAQUET Holding B.V. & Co. Kg. (Getinge Group): Geographical Revenue
Figure 31 Cohera Medical Inc.: Key Financials
Figure 32 Cohera Medical Inc.: Segmental Revenue
Figure 33 Cohera Medical Inc.: Geographical Revenue
Figure 34 Integra Lifesciences Holdings Corporation: Key Financials
Figure 35 Integra Lifesciences Holdings Corporation: Segmental Revenue
Figure 36 Integra Lifesciences Holdings Corporation: Geographical Revenue
Figure 37 Commonwealth Serum Laboratories (CSL) : Key Financials
Figure 38 Commonwealth Serum Laboratories (CSL) : Segmental Revenue
Figure 39 Commonwealth Serum Laboratories (CSL) : Geographical Revenue
Figure 40 Hemostasis, LLC: Key Financials
Figure 41 Hemostasis, LLC: Segmental Revenue
Figure 42 Hemostasis, LLC: Geographical Revenue
Figure 43 Sanofi: Key Financials
Figure 44 Sanofi: Segmental Revenue
Figure 45 Sanofi: Geographical Revenue
Figure 46 Stryker Corporation: Key Financials
Figure 47 Stryker Corporation: Segmental Revenue
Figure 48 Stryker Corporation: Geographical Revenue
Figure 49 Pfizer, Inc.: Key Financials
Figure 50 Pfizer, Inc.: Segmental Revenue
Figure 51 Pfizer, Inc.: Geographical Revenue
Figure 52 Cryolife, Inc.: Key Financials
Figure 53 Cryolife, Inc.: Segmental Revenue
Figure 54 Cryolife, Inc.: Geographical Revenue
Figure 55 Kuros Biosciences Ltd.: Key Financials
Figure 56 Kuros Biosciences Ltd.: Segmental Revenue
Figure 57 Kuros Biosciences Ltd.: Geographical Revenue